摘要
目的探讨凝血功能及全血粘度在糖尿病及其并发症中的临床价值。方法对54例糖尿病有微血管病变患者、52例糖尿病无微血管病变患者和50例正常对照组血浆的纤维蛋白原(FIB)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、全血粘度进行检测。结果糖尿病有微血管病变组PT、APTT、TT均低于糖尿病无微血管病变组和对照组,而全血粘度高于糖尿病无微血管病变组和对照组,糖尿病组FIB均增高,且有微血管病变组高于无微血管病变组,差异均有统计学意义(P<O.05)。结论检测凝血功能指标和全血粘度,对糖尿病微血管病变患者的病情预测和早期诊治有重要意义。
Objective To explore the clinical value about coagulation function and whole blood viscosity in diabetes and its complications. Methods We choose 54,52 diabetes patients without Diabetic microvascular complication and 50 cases normal control group as research object to test plasma fibrinogen（ FIB ）, prothrombin time（ PT）, activated partial thrombintime （APTT）, thromhin time （TT）and whole blood viscosity. Results PT, APTT and TT of diabetes patients with Diabetic microvascular complication are lower than those of time without Diabetic microvascular complication group and normal control group, the whole blood viscosity of diabetes patients with Diabetic microvascular complication is higher than that of diabetes patients without Diabetic microvascular complication and normal control group, but FIB of diabetes groups are all increased and FIB of diabetes patients with Diabetic microvascular complication is higher than diabetes patients without Diabetic microvascular complication, the different have a statistically significant （P 〈 0. 05）. Conclusion It is important for early diagnosis and treatment to test coagulation function and whole blood viscosity in diabetes and its complications.
出处
《中外医学研究》
2011年第31期30-31,共2页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
糖尿病
凝血功能
全血粘度
Diabetes
Coagulation
Whole blood viscosity
